Early biomarkers as predictors for bronchopulmonary dysplasia in preterm infants: A systematic review

European Journal of Pediatrics

Volumn 173, Issue 1, 2014, Pages 15-23

  Zhang, Zhi Qun ^a   Huang, Xian Mei ^a   Lu, Hui ^a  

^a HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

Biomarkers; Bronchopulmonary dysplasia; Early diagnosis; Preterm infants

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CC16 PROTEIN; END TIDAL CARBON MONOXIDE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GROWTH FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; KERATINOCYTE GROWTH FACTOR; KL 6 PROTEIN; LYSOSOME ENZYME; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PLACENTAL GROWTH FACTOR; SOLUBLE GLYCOPROTEIN 130; UNCLASSIFIED DRUG;

BIBLIOGRAPHIC DATABASE; BLOOD LEVEL; BRAIN DEVELOPMENT; EARLY DIAGNOSIS; EMBASE; EXPIRATORY FLOW; GOOGLE SCHOLAR; HUMAN; INSPIRATORY CAPACITY; LUNG DYSPLASIA; LUNG LAVAGE; MEDLINE; NEUTROPHIL COUNT; PREDICTIVE VALUE; PREMATURITY; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TRACHEAL ASPIRATION PROCEDURE; URINE;

BIOLOGICAL MARKERS; BRONCHOPULMONARY DYSPLASIA; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; SENSITIVITY AND SPECIFICITY;

EID: 84893712611     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-013-2148-7     Document Type: Review

References (40)

1. Altiok O, Yasumatsu R, Bingol-Karakoc G, Riese RJ, Stahlman MT, Dwyer W, Pierce RA, Bromme D, Weber E, Cataltepe S (2004) MMP-2 and MMP-9 and their tissue inhibitors in the plasma of preterm and term neonates. Pediatr Res 55:794-801
2. Altiok O, Yasumatsu R, Bingol-Karakoc G, Riese RJ, Stahlman MT, Dwyer W, Pierce RA, Bromme D, Weber E, Cataltepe S (2006) Imbalance between cysteine proteases and inhibitors in a baboon model of bronchopulmonary dysplasia. Am J Respir Crit Care Med 173:318-326
3. Been JV, Debeer A, van Iwaarden JF, Kloosterboer N, Passos VL, Naulaers G, Zimmermann LJ (2010) Early alterations of growth factor patterns in bronchoalveolar lavage fluid from preterm infants developing bronchopulmonary dysplasia. Pediatr Res 67:83-89
4. Blok CA, Krediet TG, Kavelaars A, Koopman-Esseboom C, Vreman HJ, Van Bel F (2011) Early end-tidal carbon monoxide levels and neurodevelopmental outcome at 3 years 6 months of age in preterm infants. Dev Med Child Neurol 53:1113-1118
5. Bose CL, Dammann CE, Laughon MM (2008) Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate. Arch Dis Child Fetal Neonatal Ed 93:455-461
6. Choi CW, Kim BI, Kim HS, Park JD, Choi JH, Son DW (2006) Increase of interleukin-6 in tracheal aspirate at birth: a predictor of subsequent bronchopulmonary dysplasia in preterm infants. Acta Pediatrica 95:38-43
7. Czernik C, Metze B, Müller C, Müller B, Bührer C (2011) Urinary N-terminal B-type natriuretic peptide predicts severe retinopathy of prematurity. Pediatrics 128:545-549
8. Danan C, Franco ML, Jarreau PH, Dassieu G, Chailley-Heu B, Bourbon J, Delacourt C (2002) High concentrations of keratinocyte growth factor in airways of premature infants predicted absence of bronchopulmonary dysplasia. Am J Respir Crit Care Med 165:1384-1387
9. Davies PL, Spiller OB, Beeton ML, Maxwell NC, Remold-O'Donnell E, Kotecha S (2010) Relationship of proteinases and proteinase inhibitors with microbial presence in chronic lung disease of prematurity. Thorax 65:246-251
10. Ekekezie II, Thibeault DW, Simon SD, Norberg M, Merrill JD, Ballard RA, Ballard PL, Truog WE (2004) Low levels of tissue inhibitors of metalloproteinases with a high matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio are present tracheal aspirate fluids of infants who develop chronic lung disease. Pediatrics 113:1709
11. Ellsbury DL, Acarregui MJ, McGuiness GA, Klein JM (2002) Variability in the use of supplemental oxygen for bronchopulmonary dysplasia. J Pediatr 149:247-249
12. Garingo A, Tesoriero L, Cayabyab R, Durand M, Blahnik M, Sardesai S, Ramanathan R, Jones C, Kwong K, Li C, Minoo P (2007) Constitutive IL-10 expression by lung inflammatory cells and risk for bronchopulmonary dysplasia. Pediatr Res 61:197-202
13. Goi G, Bairati C, Massaccesi L, Lombardo A, Bonafè L, Zanardo V, Burlina A (1998) Lysosomal enzymes in preterm infants with bronchopulmonary dysplasia: a potential diagnostic marker. Clin Chim Acta 278:23-34
14. Hasan J, Beharry KD, Valencia AM, Strauss A, Modanlou HD (2009) Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease. Pediatrics 123:1541-1547
15. Horbar JD, Badger GJ, Carpenter JH, Fanaroff AA, Kilpatrick S, LaCorte M, Phibbs R, Soll RF (2002) Trends in mortality and morbidity for very low birth weight infants, 1991-1999. Pediatrics 110:143-151
16. Inoue H, Ohga S, Kusuda T, Kitajima J, Kinjo T, Ochiai M, Takahata Y, Honjo S, Hara T (2013) Serum neutrophil gelatinase-associated lipocalin as a predictor of the development of bronchopulmonary dysplasia in preterm infants. Early Hum Dev 89:425-429
17. Jobe AH, Bancalari E (2001) Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163:1723-1729
18. Kaukola T, Tuimala J, Herva R, Kingsmore S, Hallman M (2009) Cord immunoproteins as predictors of respiratory outcome in preterm infants. Am J Obstet Gynecol 200:1-8
19. Kim BI, Lee HE, Choi CW, Jo HS, Choi EH, Koh YY, Choi JH (2004) Increase in cord blood soluble E-selectin and tracheal aspirate neutrophils at birth and the development of new bronchopulmonary dysplasia. J Perinatol Med 32:282-287
20. Kinsella JP, Greenough A, Abman SH (2006) Bronchopulmonary dysplasia. Lancet 367:1421-1431
21. Krediet TG, Cirkel GA, Vreman HJ, Wong RJ, Stevenson DK, Groenendaal F, Egberts J, Van Bel F (2006) End-tidal carbon monoxide measurements in infant respiratory distress syndrome. Acta Pediatrica 95:1075-1082
22. Löfqvist C, Hellgren G, Niklasson A, Engström E, Ley D, Hansen-Pupp I (2012) Low postnatal serum IGF-I levels are associated with bronchopulmonary dysplasia (BPD). Acta Pediatrica 101:1211-1216
23. Makinde T, Agrawal DK (2008) Intra and extra-vascular trans-membrane signaling of angiopoietin-1-Tie2 receptorin health and disease. J Cell Mol Med 12:810-828
24. May C, Patel S, Kennedy C, Pollina E, Rafferty GF, Peacock JL, Greenough A (2011) Prediction of bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed 96:410-416
25. May C, Patel S, Peacock J, Milner A, Rafferty GF, Greenough A (2007) End-tidal carbon monoxide levels in prematurely born infants developing bronchopulmonary dysplasia. Pediatr Res 61:474-478
26. McGowan EC, Kostadinov S, McLean K, Gotsch F, Venturini D, Romero R, Laptook AR, Sharma S (2009) Placental IL-10 dysregulation and association with bronchopulmonary dysplasia risk. Pediatr Res 66:455-460
27. Mohamed WA, Niyazy WH, Mahfouz AA (2011) Angiopoietin-1 and endostatin levels in cord plasma predict the development of bronchopulmonary dysplasia in preterm infants. J Trop Pediatr 57:385-388
28. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097
29. Munshi UK, Niu JO, Siddiq MM, Parton LA (1997) Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatr Pulmonol 24:331-336
30. Ogihara T, Hirano K, Morinobu T, Kim HS, Ogawa S, Hiroi M, Oue S, Ban R, Hira S, Hasegawa M, Yamaoka S, Yasui M (2006) Plasma KL-6 predicts the development and outcome of bronchopulmonary dysplasia. Pediatr Res 60:613-618
31. Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P (2004) Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 159:882-890
32. Ramsay PL, DeMayo FJ, Hegemier SE, Wearden ME, Smith CV, Welty SE (2001) Clara cell secretory protein oxidation and expression in premature infants who develop bronchopulmonary dysplasia. Am J Respir Crit Care Med 164:155-161
33. Sarafidis K, Stathopoulou T, Diamanti E, Soubasi V, Agakidis C, Balaska A, Drossou V (2008) Clara cell secretory protein (CC16) as a peripheral blood biomarker of lung injury in ventilated preterm neonates. Eur J Pediatr 167:1297-1303
34. Schrama AJ, Bernard A, Poorthuis BJ, Zwinderman AH, Berger HM, Walther FJ (2008) Cord blood Clara cell protein CC16 predicts the development of bronchopulmonary dysplasia. Eur J Pediatr 167:1305-1312
35. Thomas W, Seidenspinner S, Kramer BW, Kawczyńska-Leda N, Chmielnicka-Kopaczyk M, Marx A, Wirbelauer J, Szymankiewicz M, Speer CP (2009) Airway concentrations of angiopoietin-1 and endostatin in ventilated extremely premature infants are decreased after funisitis and unbalanced with bronchopulmonary dysplasia/death. Pediatr Res 65:468-473
36. Tsao PN, Wei SC, Su YN, Lee CN, Chou HC, Hsieh WS, Hsieh FJ (2004) Placenta growth factor elevation in the cord blood of premature neonates. Pediatrics 113:1348-1351
37. Vento G, Tirone C, Lulli P, Capoluongo E, Ameglio F, Lozzi S, Cota F, Mosca F, Romagnoli C, Messana I, Castagnola M, Inzitari R (2009) Bronchoalveolar lavage fluid peptidomics suggests a possible matrix metalloproteinase-3 role in bronchopulmonary dysplasia. Intensive Care Med 35:2115-2124
38. Walsh MC, Yao Q, Gettner P et al (2004) Impact of a physiologic defi nition on BPD rates. Pediatrics 114:1305-1311
39. Whiting P, Rutjes A, Reitsma J, Bossuyt P, Kleijnen J (2003) The development of QUADAS: a tool for the quality adjustment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3:25
40. Yanamandra K, Boggs P, Loggins J, Baier RJ (2005) Interleukin-10-1082 G/A polymorphism and risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infants. Pediatr Pulmonol 39:426-432